wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q44720968-EAF0CD5C-5E2A-442E-B605-07EC0A607154
Q44720968-EAF0CD5C-5E2A-442E-B605-07EC0A607154
BestRank
Statement
http://www.wikidata.org/entity/statement/Q44720968-EAF0CD5C-5E2A-442E-B605-07EC0A607154
Histiocytic sarcoma - targeted therapy: novel therapeutic options? A series of 4 cases.
P2860
Q44720968-EAF0CD5C-5E2A-442E-B605-07EC0A607154
BestRank
Statement
http://www.wikidata.org/entity/statement/Q44720968-EAF0CD5C-5E2A-442E-B605-07EC0A607154
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0b3f69f83a2f10b523ea87f10cb677af718349a1
P2860
A phase II trial of single agent bevacizumab in patients with relapsed, aggressive non-Hodgkin lymphoma: Southwest oncology group study S0108.